Mirador Capital Partners LP Makes New Investment in Astera Labs, Inc. $ALAB

Key Points

• Mirador Capital Partners LP has made a significant investment in Astera Labs, Inc., purchasing 17,783 shares valued at approximately $1.6 million during the second quarter.
• Astera Labs reported a strong earnings performance, with a revenue increase of 149.5% year-over-year, and earnings per share of $0.44, surpassing analysts' expectations.
• Insider selling activity has been notable, with CEO Jitendra Mohan selling over 91,000 shares for approximately $16.8 million, indicating a 4.04% decrease in his position.

Mirador Capital Partners LP purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 17,783 shares of the company's stock, valued at approximately $1,608,000.

A number of other hedge funds have also recently made changes to their positions in the business. New England Research & Management Inc. acquired a new position in shares of Astera Labs during the second quarter valued at about $1,250,000. Teamwork Financial Advisors LLC acquired a new position in shares of Astera Labs during the second quarter valued at about $226,000. Salem Investment Counselors Inc. acquired a new position in shares of Astera Labs during the second quarter valued at about $15,900,000. Rhumbline Advisers grew its holdings in shares of Astera Labs by 4.4% during the first quarter. Rhumbline Advisers now owns 104,345 shares of the company's stock valued at $6,226,000 after buying an additional 4,396 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Astera Labs by 1,382.7% during the first quarter. Geneos Wealth Management Inc. now owns 4,033 shares of the company's stock valued at $241,000 after buying an additional 3,761 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Trading Up 3.2%

Astera Labs stock opened at $238.79 on Wednesday. The firm's 50 day simple moving average is $160.88 and its 200 day simple moving average is $106.04. The firm has a market capitalization of $39.69 billion, a PE ratio of 426.41, a price-to-earnings-growth ratio of 5.87 and a beta of 1.48. Astera Labs, Inc. has a 1-year low of $44.40 and a 1-year high of $241.29.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs's revenue was up 149.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 91,441 shares of the company's stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief executive officer owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jack R. Lazar sold 22,500 shares of the company's stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the sale, the director directly owned 97,351 shares in the company, valued at $17,369,365.42. This trade represents a 18.77% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,649,606 shares of company stock worth $246,588,601 in the last ninety days. Insiders own 12.50% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. CICC Research assumed coverage on shares of Astera Labs in a report on Friday, August 29th. They set an "outperform" rating and a $190.00 price objective for the company. Northland Capmk lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Evercore ISI raised their price target on shares of Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, August 6th. Stifel Nicolaus set a $145.00 price target on shares of Astera Labs and gave the company a "buy" rating in a research report on Monday, August 4th. Finally, Susquehanna raised their price target on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $142.00.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.